Assessing Methotrexate Adherence in Juvenile Idiopathic Arthritis Using Electronic Health Record-Linked Pharmacy Dispensing Data

Juvenile Idiopathic Arthritis

Factors for Consideration by Pediatric Rheumatologists When Scoring the Physician Global Assessment (PhGA) of Disease Activity in Juvenile Idiopathic Arthritis: First Step Toward an Internal Consensus

Arthritis Care Res (Hoboken)

Tarkiainen M, Balay-Dustrude E, Consolaro A, Morgan EM, Ruperto N, Rypdal V, Backström M, Vähäsalo P, Gottlieb BS, Paediatric Rheumatology International Trials Organisation, and the Pediatric Rheumatology Care & Outcomes Improvement Network and the PhGA consensus task force, For the Pediatric Rheumatology European Society (PRES) JIA working party

doi: 10.1002/acr.25447

Psoriatic Arthritis

Adherence, Persistence, Healthcare Resource Use, and Costs in Tofacitinib-Treated Patients with Psoriatic Arthritis: Data from Two United States Claims Databases

Adv Ther

Mease PJ, Papademetriou E, Potluri R, Agarwal E, Cappelleri JC, Ling YL

doi: 10.1007/s12325-024-02904-y

Juvenile Idiopathic Arthritis

Transcriptomic profiling and immuno-histological characterization of synovial biopsies in juvenile idiopathic arthritis (JIA) suggest two broad categories, with significant overlap with rheumatoid arthritis (RA)

Arthritis Rheumatol

Triaille C, Tilman G, Baert CA, Sokolova T, Loriot A, Nzeusseu-Toukap A, Meric de Bellefon L, Galant C, Boulanger C, Fonseca JE, Bouzin C, Durez P, Lauwerys BR, Limaye N

doi: 10.1002/art.42922

Systemic Lupus Erythematosus

Peripartum maternal outcomes in individuals with systemic lupus erythematosus in a real-world electronic health record cohort

Semin Arthritis Rheum

Deffendall C, Green S, Suh A, Nikolova N, Walker K, Whitney R, Wheless L, Osmundson S, Barnado A

doi: 10.1016/j.semarthrit.2024.152603

Juvenile Idiopathic Arthritis

Juvenile Idiopathic Arthritis, Earnings and Work Loss: A Nationwide Matched Cohort Study

Arthritis Care Res (Hoboken)

Miller H, Neovius M, Sundberg E, Askling J, Bruze G

doi: 10.1002/acr.25522

EULAR 2024

Juvenile Idiopathic Arthritis

Canakinumab is effective as a first-line steroid-free treatment for patients with systemic juvenile idiopathic arthritis

Juvenile Idiopathic Arthritis

Integration of genetic and clinical risk factors improves the risk classification of uveitis in patients with juvenile idiopathic arthritis

Arthritis Rheumatol

Tordoff M, Smith SL, Lawson-Tovey S, UK JIA Biologics Register, CAPS, CHARMS, CLUSTER, JIAGC, Dick AD, Beresford MW, Ramanan AV, Hyrich KL, Morris AP, Eyre S, Wedderburn LR, Bowes J, CLUSTER consortium

doi: 10.1002/art.42955

Juvenile Idiopathic Arthritis

Exploring pain adaptation in youth with juvenile idiopathic arthritis: Identifying youth and parent resilience resources and mechanisms

Arthritis Care Res (Hoboken)

Brandelli YN, Mackinnon SP, Chambers CT, Parker JA, Huber AM, Stinson JN, Johnson SA, Wilson JP

doi: 10.1002/acr.25439

Juvenile Idiopathic Arthritis

Intravenous Golimumab in Children with Polyarticular-Course Juvenile Idiopathic Arthritis: Long-term Extension of an Open-label, Phase 3 Study

J Rheumatol

Brunner HI, Pacheco-Tena C, Louw I, Vega-Cornejo G, Alexeeva E, Appenzeller S, Chasnyk V, Griffin T, Navarrete Suarez C, Knupp-Oliveira S, Zeft A, Butbul Aviel Y, De Ranieri D, Gottlieb BS, Levy DM, Rabinovich CE, Artur Silva C, Spivakovsky Y, Uziel Y, Ringold S, Xu XL, Leu JH, Lam E, Wang Y, Lovell DJ, Martini A, Ruperto N, Pediatric Rheumatology Collaborative Study Group (PRCSG) and Paediatric Rheumatology INternational Trials Organisation (PRINTO)

doi: 10.3899/jrheum.2024-0298

Related content

Factors for Consideration by Pediatric Rheumatologists When Scoring the Physician Global Assessment (PhGA) of Disease Activity in Juvenile Idiopathic Arthritis: First Step Toward an Internal Consensus

Adherence, Persistence, Healthcare Resource Use, and Costs in Tofacitinib-Treated Patients with Psoriatic Arthritis: Data from Two United States Claims Databases

Transcriptomic profiling and immuno-histological characterization of synovial biopsies in juvenile idiopathic arthritis (JIA) suggest two broad categories, with significant overlap with rheumatoid arthritis (RA)

Peripartum maternal outcomes in individuals with systemic lupus erythematosus in a real-world electronic health record cohort

Juvenile Idiopathic Arthritis, Earnings and Work Loss: A Nationwide Matched Cohort Study

Canakinumab is effective as a first-line steroid-free treatment for patients with systemic juvenile idiopathic arthritis

Integration of genetic and clinical risk factors improves the risk classification of uveitis in patients with juvenile idiopathic arthritis

Exploring pain adaptation in youth with juvenile idiopathic arthritis: Identifying youth and parent resilience resources and mechanisms

Intravenous Golimumab in Children with Polyarticular-Course Juvenile Idiopathic Arthritis: Long-term Extension of an Open-label, Phase 3 Study